Inogen (INGN) PT Lifted to $46 at Needham & Company
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
Inogen Announces Fourth Quarter and Full Year 2014 Financial Results and Updates 2015 Outlook
April 27, 2015 6:30 AM EDT- Full Year 2014 Revenue of $112.5 Million Exceeds Guidance, Up 49.2% Year over Year - - Strong Q4 2014 Revenue Growth of 47.3% Year over Year - - Raises 2015 Full Year Revenue Guidance -
GOLETA, Calif., April 27, 2015 (GLOBE NEWSWIRE) -- Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the home care setting, today reported financial results for the three and twelve months ended December 31, 2014.
Fourth Quarter 2014 Financial Highlights
Total revenue of $29.1 million, up 47.3% over the... More